Comparison of oxidative stress biomarkers in hypertensive patients with or without hyperhomocysteinemia

References

• Ganguly P, Alam SF. Role of homocysteine in the development of cardiovascular disease. Nutr J. 2015;14:6.
   PubMed Web of Science ®Google Scholar
• Lai WK, Kan MY. Homocysteine-induced endothelial dysfunction. Ann Nutr Metab. 2015;67:1–12.
   PubMed Web of Science ®Google Scholar
• Liu J, Xu Y, Zhang H, et al. Coronary flow velocity reserve is impaired in hypertensive patients with hyperhomocysteinemia. J Hum Hypertens. 2014;28:743–47.
   PubMed Web of Science ®Google Scholar
• Xiao W, Bai Y, Ye P, et al. Plasma homocysteine is associated with aortic arterial stiffness but not wave reflection in Chinese hypertensive subjects, PLoS One, 2014;27(9):e85938.
   Google Scholar
• Wang CY, Chen ZW, Zhang T, et al. Elevated plasma homocysteine level is associated with ischemic stroke in Chinese hypertensive patients. Eur J Intern Med. 2014;25:538–44.
   PubMed Web of Science ®Google Scholar
• Zheng H, Li Y, Xie N, et al. Echocardiographic assessment of hypertensive patients with or without hyperhomocysteinemia. Clin Exp Hypertens. 2014;36:181–86.
   PubMed Web of Science ®Google Scholar
• de Koning EJ, van der Zwaluw NL, van Wijngaarden JP, et al. Effects of two-year vitamin b12 and folic acid supplementation on depressive symptoms and quality of life in older adults with elevated homocysteine concentrations: additional results from the b-proof study, an RCT, Nutrients, 2016;8(11):pii: E748.
   PubMed Web of Science ®Google Scholar
• Cellai AP, Lami D, Antonucci E, et al. Hyperhomocysteinemia in patients with pulmonary embolism is associated with impaired plasma fibrinolytic capacity. J Thromb Thrombolysis. 2014;38:45–49.
   PubMed Web of Science ®Google Scholar
• Huo Y, Li J, Qin X, et al. Efficacy of folic acid therapy in primary prevention of stroke among adults with hypertension in China: the CSPPT randomized clinical trial, JAMA, 2015;313(13):1325–35.
   PubMed Web of Science ®Google Scholar
• Liu LS. Writing group of 2010 Chinese guidelines for the management of hypertension.2010 Chinese guidelines for the management of hypertension. Zhonghua Xin Xue Guan Bing Za Zhi. 2011;39:579–615.
   PubMedGoogle Scholar
• Cervantes Gracia K, Llanas-Cornejo D, Husi H. CVD and oxidative stress. J Clin Med. 2017;6:pii: E22.
   PubMed Web of Science ®Google Scholar
• Montezano AC, Touyz RM. Oxidative stress, Noxs, and hypertension: experimental evidence and clinical controversies. Ann Med. 2012;44(Suppl 1):S2–16.
   PubMedGoogle Scholar
• de Champlain J, Wu R, Girouard H, et al. Oxidative stress in hypertension. Clin Exp Hypertens. 2004;26:593–601.
   PubMed Web of Science ®Google Scholar
• Kashyap MK, Yadav V, Sherawat BS, et al. Different antioxidants status, total antioxidant power and free radicals in essential hypertension. Mol Cell Biochem. 2005;277:89–99.
   PubMed Web of Science ®Google Scholar
• Rodrigo R, Prat H, Passalacqua W, et al. Relationship between oxidative stress and essential hypertension. Hypertens Res. 2007;30:1159–67.
   PubMed Web of Science ®Google Scholar
• Curgunlu A, Uzun H, Bavunoğlu I, et al. Increased circulating concentrations of asymmetric dimethylarginine (ADMA) in white coat hypertension. J Hum Hypertens. 2005;19:629–33.
   PubMed Web of Science ®Google Scholar
• Guven A, Tolun F, Caliskan M, et al. C-reactive protein and nitric oxide level in patients with white coat hypertension. Blood Press. 2012;21:281–85.
   PubMed Web of Science ®Google Scholar
• Napoli C, Sica V, de Nigris F, et al. Sulfhydryl angiotensin converting enzyme inhibition induces sustained reduction of systemic oxidative stress and improves the nitric oxide pathway in patients with essential hypertension, Am Heart J, 2004;148(1):e5.
   PubMed Web of Science ®Google Scholar
• Lerman LO, Nath KA, Rodriguez-Porcel M, et al. Increased oxidative stress in experimental renovascular hypertension. Hypertension. 2001;37:541–46.
   PubMed Web of Science ®Google Scholar
• Reckelhoff JF, Zhang H, Srivastava K, et al. Subpressor doses of angiotensin II increase plasma F(2)-isoprostanes in rats. Hypertension. 2000;35:476–79.
   PubMed Web of Science ®Google Scholar
• Hozawa A, Ebihara S, Ohmori K, et al. Increased plasma 8-isoprostane levels in hypertensive subjects: the Tsurugaya Project. Hypertens Res. 2004;27:557–61.
   PubMed Web of Science ®Google Scholar
• de Faria AP, Fontana V, Modolo R, et al. Plasma 8-isoprostane levels are associated with endothelial dysfunction in resistant hypertension. Clin Chim Acta. 2014;433:179–83.
   PubMed Web of Science ®Google Scholar
• Schnackenberg CG, Wilcox CS. Two week administration of tempol attenuates both hypertension and renal excretion of 8-Isoprostaglandin f2alpha. Hypertension. 1999;33:424–28.
   PubMed Web of Science ®Google Scholar
• Badr KF, Abi-Antoun TE. Isoprostanes and the kidney. Antioxid Redox Signal. 2005;7:236–43.
   PubMed Web of Science ®Google Scholar
• Rodrigo R, Libuy M, Feliú F, et al. Oxidative stress-related biomarkers in essential hypertension and ischemia-reperfusion myocardial damage. Dis Markers. 2013;35:773–90.
   PubMed Web of Science ®Google Scholar
• Yilmaz R, Horoz M, Kocyiqit A, et al. Lymphocyte DNA damage and total antioxidant status in patients with white-coat hypertension and sustained hypertension. Turk Kardiyol Dern Ars. 2008;36:231–38.
   PubMedGoogle Scholar
• Chrysohoou C, Panagiotakos DB, Pitsavos C, et al. The association between prehypertension status and oxidative stress markers related to atherosclerotic disease: the ATTICA study. Atherosclerosis. 2007;192:169–76.
   PubMed Web of Science ®Google Scholar
• Zujko ME, Witkowska AM, Górska M, et al. Reduced intake of dietary antioxidants can impair antioxidant status in type 2 diabetes patients. Pol Arch Med Wewn. 2014;124:599–607.
   PubMed Web of Science ®Google Scholar
• Juraschek SP, Guallar E, Appel LJ, et al. Effects of vitamin C supplementation on blood pressure: a meta-analysis of randomized controlled trials. Am J Clin Nutr. 2012;95:1079–88.
   PubMed Web of Science ®Google Scholar
• John JH, Ziebland S, Yudkin P, Roe LS, Neil HAW. Oxford fruit and vegetable studygroup. Effects of fruit and vegetable consumption on plasma antioxidant concentrations and blood pressure: a randomised controlled trial. Lancet. 2002;359:1969–74.
   PubMed Web of Science ®Google Scholar
• Cervellati C, Bergamini CM. Oxidative damage and the pathogenesis of menopause related disturbances and diseases. Clin Chem Lab Med. 2016;54:739–53.
   PubMed Web of Science ®Google Scholar
• San Miguel SM, Opperman LA, Allen EP, Svoboda KK. Reactive oxygen species and antioxidant defense mechanisms in the oral cavity: a literature review. Compend Contin Educ Dent. 2011;32:E10–5.
   PubMedGoogle Scholar